FAST vs NRIX · P/E 43, rev $7.55B vs rev $54.5M
Fastenal Company (FAST) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
FAST currently screens at market cap $49.48B and trailing P/E 43.1. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the FAST and NRIX stock pages for the full models.
Not investment advice.